<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>STATROL- neomycin sulfate and polymyxin b sulfate ointment </strong><br>ALCON LABORATORIES, INC.<br></p></div>
<h1>Statrol®<br>neomycin and polymyxin B<br>sulfates ophthalmic ointment, USP</h1>
<div class="Contents">
<div class="Section">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1> DESCRIPTION</h1>
<p class="First">STATROL® (Neomycin and Polymyxin B Sulfates Ophthalmic Ointment, USP) is a sterile ophthalmic drug combining two antibacterials in ointment form.</p>
<p>Each gram of ointment contains: <span class="Bold">Active</span>: Neomycin Sulfate equivalent to 3.5 mg Neomycin base, Polymyxin B Sulfate equal to 10,000 polymyxin B units.</p>
<p><span class="Bold">Preservatives</span>: Methylparaben 0.05%, Propylparaben 0.01%. <span class="Bold">Inactive:</span> White Petrolatum, Anhydrous Liquid Lanolin. DM-01</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1> CLINICAL PHARMACOLOGY</h1>
<p class="First">The anti-infective components in STATROL Ophthalmic Ointment provide action against specific organisms susceptible to them.  Polymyxin B Sulfate and Neomycin Sulfate are active <span class="Italics">in vitro </span>against <span class="Italics">Staphylococcus aureus, Escherichia coli, </span><span class="Italics">Klebsiella/Enterobacter</span> species, <span class="Italics">Neisseria </span>species, <span class="Italics">Pseudomonas aeruginosa</span>. This product does not provide adequate coverage against: <span class="Italics">Serratia marcescens, </span> Streptococci, including <span class="Italics">Streptococcus pneumoniae.</span></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1> INDICATIONS AND USAGE</h1>
<p class="First">STRATOL Ophthalmic Ointment is indicated in the topical treatment of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> of the external eye and its adnexa caused by susceptible bacteria.  Such <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> encompass <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span>, and <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratoconjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="378425" conceptname="Blepharitis">blepharitis</span> and <span class="product-label-link" type="condition" conceptid="374347" conceptname="Blepharoconjunctivitis">blepharoconjunctivitis</span>, acute <span class="product-label-link" type="condition" conceptid="4146941" conceptname="Meibomianitis">meibomianitis</span> and dacryocystitis.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1> CONTRAINDICATIONS</h1>
<p class="First">Epithelial <span class="product-label-link" type="condition" conceptid="373404" conceptname="Ophthalmic herpes simplex">herpes simplex keratitis</span> (<span class="product-label-link" type="condition" conceptid="373404" conceptname="Ophthalmic herpes simplex">dendritic keratitis</span>), <span class="product-label-link" type="condition" conceptid="140633" conceptname="Vaccinia">vaccinia</span>, <span class="product-label-link" type="condition" conceptid="434272" conceptname="Varicella">varicella</span>, and many other viral diseases of the cornea and conjunctiva.  <span class="product-label-link" type="condition" conceptid="4009326" conceptname="Mycobacterial infection">Mycobacterial infection</span> of the eye.  Fungal diseases of ocular structures.  <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span> to a component of the medication.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1> WARNINGS</h1>
<p class="First">NOT FOR INJECTION INTO THE EYE.  Should a sensitivity reaction occur, discontinue use.  Ophthalmic ointments may retard corneal <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wound</span> healing.  Neomycin Sulfate may cause cutaneous sensitization.  Remove contact lenses before using.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1> PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-7.1"></a><p></p>
<h2> General</h2>
<p class="First">As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms including fungi.  If <span class="product-label-link" type="condition" conceptid="4105019" conceptname="Superimposed infection">superinfection</span> occurs, appropriate measures should be initiated.  Whenever clinical judgment dictates; the patient should be examined with the aid of magnification, such as slit lamp biomicroscopy, and, where appropriate, <span class="product-label-link" type="condition" conceptid="4080997" conceptname="Corneal epithelial staining pattern">corneal staining</span>.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7.2"></a><p></p>
<h2> Information for Patients</h2>
<p class="First">This product is sterile when packaged.  To prevent contamination, care should be taken to avoid touching the tube tip to eyelids or to any other surface.  The use of this tube by more than one person may spread <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span>.  Keep tube tightly closed when not in use.  Keep out of the reach of children.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-7.3"></a><p></p>
<h2> Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Long-term studies in animals to evaluate  carcinogenic or mutagenic potential have not been conducted with Polymyxin B Sulfate.  Treatment of cultured human <span class="product-label-link" type="condition" conceptid="4254663" conceptname="Lymphocyte count">lymphocytes</span> <span class="Italics">in-vitro </span>with neomycin increased the frequency of chromosome aberrations at the highest concentrations (80 µg/mL) tested; however, the effects of neomycin on carcinogenesis and mutagenesis in humans are unknown.</p>
<p>Polymyxin B Sulfate has been reported to impair the motility of equine sperm, but its effects on male or female fertility are unknown.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-7.4"></a><p></p>
<h2> Pregnancy</h2>
<p class="First"></p>
<div class="Section" data-sectionCode="34077-8">
<a name="section-7.4.1"></a><p></p>
<h3> Teratogenic Enects</h3>
<p class="First"></p>
<div class="Section">
<a name="section-7.4.1.1"></a><p></p>
<h4> Pregnancy Category C.</h4>
<p class="First">Animal reproduction studies have not been conducted with STATROL® (Neomycin and Polymyxin B Sulfates Ophthalmic Ointment, USP).  It is also not known whether Neomycin Sulfate and/or Polymyxin B Sulfate can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.  STATROL Ophthalmic Ointment should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-7.5"></a><p></p>
<h2> Nursing Mothers</h2>
<p class="First">It is not known whether these drugs are excreted in human milk.  Because many drugs are excreted in human milk, caution should be exercised when STATROL Ophthalmic Ointment is administered to a nursing mother.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1> ADVERSE REACTIONS</h1>
<p class="First">Adverse reactions have occurred with the anti-infective components.  Exact incidence figures are not available since no denominator of treated patients is available.</p>
<p>Reactions occurring most often from the presence of the anti-infective ingredients are allergic sensitizations.  (SEE WARNINGS.)</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-9"></a><p></p>
<h1> DOSAGE AND ADMINISTRATION</h1>
<p class="First">Instill about a half-inch ribbon into the conjunctival sac(s) up to three or four times daily, or may be used adjunctively with the solution at bedtime.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<h1> HOW SUPPLIED</h1>
<p class="First">STATROL (Neomycin and Polymyxin B Sulfates Ophthalmic Ointment, USP) in 3.5 g ophthalmic tube: <span class="Bold">NDC </span> 0065-0624-36. </p>
<p><span class="Bold">STORAGE: </span>Store at 46° - 80°F (8° - 27°C).</p>
<p>Federal (USA) law prohibits dispensing without prescription.</p>
<p><span class="Bold">Alcon®</span></p>
<p><span class="Bold">OPHTHALMIC</span></p>
<p><span class="Bold">ALCON LABORATORIES, INC.</span></p>
<p>Fort Worth, Texas; 76134; USA</p>
<p>Revised: June 1995</p>
<p>Printed in USA </p>
<p>298392</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>STATROL 		
					</strong><br><span class="contentTableReg">neomycin sulfate and polymyxin b sulfate ointment</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0065-0624</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>neomycin sulfate</strong> (neomycin) </td>
<td class="formItem"></td>
<td class="formItem">3.5 mg  in 1 g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>polymyxin B sulfate</strong> (polymyxin B) </td>
<td class="formItem"></td>
<td class="formItem">10000   in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>methylparaben</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>propylparaben</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>white petrolatum</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>anhydrous liquid lanolin</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0065-0624-36</td>
<td class="formItem">3.5 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>ALCON LABORATORIES, INC.</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 5/2006<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>7341D8AC-5DCF-DC6C-D97C-9887FB917DB0</div>
<div>Set id: 34fd1318-c6ce-4116-bffa-57263fca27d2</div>
<div>Version: 1</div>
<div>Effective Time: 20060512</div>
</div>
</div> <div class="DistributorName">ALCON LABORATORIES, INC.</div></p>
</body></html>
